# REstore Working Ability in RheumatoiD Arthritis

> **NCT01405326** · PHASE4 · UNKNOWN · sponsor: **The Rheumatological Center of Helsinki** · enrollment: 160 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** adalimumab

## Key facts

- **NCT ID:** NCT01405326
- **Lead sponsor:** The Rheumatological Center of Helsinki
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2011-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405326, "REstore Working Ability in RheumatoiD Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01405326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*